Spark Biomedical and Velentium Named ‘Most Innovative’ in Houston
Ōmcare Joins Fellow Home Health Leaders to Discuss the Future of Care
GrandPad sees expanded adoption of telehealth platform by PACE programs
FDA signs off on change to contraindications for GE’s Optison agent